Cargando…

Measurement of the critical DNA lesions produced by antibody-directed enzyme prodrug therapy (ADEPT) in vitro, in vivo and in clinical material

An antibody-directed enzyme prodrug therapy (ADEPT) system against CEA-positive tumours is currently in phase I clinical trials. It consists of a prodrug, 4-[N,N-bis(2-iodoethyl) amino] phenoxycarbonyl L -glutamic acid (ZD2767P) and a conjugate of the F(ab')(2) anti-CEA antibody A5B7 and the ba...

Descripción completa

Detalles Bibliográficos
Autores principales:	Webley, S D, Francis, R J, Pedley, R B, Sharma, S K, Begent, R H J, Hartley, J A, Hochhauser, D
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2001
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363686/ https://www.ncbi.nlm.nih.gov/pubmed/11401322 http://dx.doi.org/10.1054/bjoc.2001.1843

Ejemplares similares

A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumours
por: Francis, R J, et al.
Publicado: (2002)

Cellular glutathione as a determinant of the sensitivity of colorectal tumour cell-lines to ZD2767 antibody-directed enzyme prodrug therapy (ADEPT)
por: Monks, N R, et al.
Publicado: (2000)

Modifying an immunogenic epitope on a therapeutic protein: a step towards an improved system for antibody-directed enzyme prodrug therapy (ADEPT)
por: Mayer, A, et al.
Publicado: (2004)

Plasma clearance of an antibody--enzyme conjugate in ADEPT by monoclonal anti-enzyme: its effect on prodrug activation in vivo.
por: Rogers, G. T., et al.
Publicado: (1995)

PDEPT: polymer-directed enzyme prodrug therapy
por: Satchi, R, et al.
Publicado: (2001)

Induction of apoptosis by the ADEPT agent ZD2767: comparison with the classical nitrogen mustard chlorambucil and a monofunctional ZD2767 analogue
por: Monks, N R, et al.
Publicado: (2001)

Dosimetric evaluation and radioimmunotherapy of anti-tumour multivalent Fab́ fragments
por: Casey, J L, et al.
Publicado: (1999)

ADEPT IN THE SCIENCES
Publicado: (1963)

In vitro assessment of Lipiodol-targeted radiotherapy for liver and colorectal cancer cell lines
por: Al-Mufti, R A M, et al.
Publicado: (1999)

New guidelines for research in airway device evaluation: time for an updated approach (ADEPT-2) to the Difficult Airway Society’s ‘ADEPT’ strategy?
por: Athanassoglou, V., et al.
Publicado: (2022)

Preclinical evaluation of the cardiac toxicity of HMR-1826, a novel prodrug of doxorubicin
por: Platel, D, et al.
Publicado: (1999)

Peripheral macrophages not ADept at amyloid clearance
por: Jay, Taylor, et al.
Publicado: (2015)

So you want to be an ADEPT Fellow?
por: Donaghy, Grainne, et al.
Publicado: (2016)

Challenges and opportunities integrating LLAMA into AdePT
por: Gruber, Bernhard Manfred, et al.
Publicado: (2023)

ADEPT - Abnormal Doppler Enteral Prescription Trial
por: Leaf, Alison, et al.
Publicado: (2009)

OneAPI for simulation: the AdePT project
por: Dosaru, Daniel-Florin
Publicado: (2021)

Performance of the high-resolution atmospheric model HRRR-AK for correcting geodetic observations from spaceborne radars
por: Gong, W, et al.
Publicado: (2013)

Bystander killing of tumour cells by antibody-targeted enzymatic activation of a glucuronide prodrug
por: Cheng, T L, et al.
Publicado: (1999)

The ability to accumulate deoxyuridine triphosphate and cellular response to thymidylate synthase (TS) inhibition
por: Webley, S D, et al.
Publicado: (2001)

Deoxyuridine triphosphatase (dUTPase) expression and sensitivity to the thymidylate synthase (TS) inhibitorD9331
por: Webley, S D, et al.
Publicado: (2000)

Clearance of circulating radio-antibodies using streptavidin or second antibodies in a xenograft model.
por: Marshall, D., et al.
Publicado: (1994)

Risk factors for radiographic progression in psoriatic arthritis: subanalysis of the randomized controlled trial ADEPT
por: Gladman, Dafna D, et al.
Publicado: (2010)

In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug
por: Grosios, K, et al.
Publicado: (1999)

Adalimumab for long-term treatment of psoriatic arthritis: 2-year data from the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT)
por: Mease, P J, et al.
Publicado: (2008)

Validated and longitudinally stable asthma phenotypes based on cluster analysis of the ADEPT study
por: Loza, Matthew J., et al.
Publicado: (2016)

GR-891: a novel 5-fluorouracil acyclonucleoside prodrug for differentiation therapy in rhabdomyosarcoma cells
por: Marchal, J A, et al.
Publicado: (1999)

Prodrugs for Gene-Directed Enzyme-Prodrug Therapy (Suicide Gene Therapy)
por: Denny, William A
Publicado: (2003)

Comparative radioimmunotherapy using intact or F(ab')2 fragments of 131I anti-CEA antibody in a colonic xenograft model.
por: Pedley, R. B., et al.
Publicado: (1993)

Radioimmunoluminography: a tool for relating tissue antigen concentration to clinical outcome
por: Boxer, G, et al.
Publicado: (1999)

A novel doxorubicin-glucuronide prodrug DOX-GA3 for tumour-selective chemotherapy: distribution and efficacy in experimental human ovarian cancer
por: Houba, P H J, et al.
Publicado: (2001)

Galactosylated streptavidin for improved clearance of biotinylated intact and F(ab')2 fragments of an anti-tumour antibody.
por: Marshall, D., et al.
Publicado: (1995)

Polyethylene glycol modification of a galactosylated streptavidin clearing agent: effects on immunogenicity and clearance of a biotinylated anti-tumour antibody.
por: Marshall, D., et al.
Publicado: (1996)

ADEPT: a domain independent sequence alignment strategy for gpu architectures
por: Awan, Muaaz G., et al.
Publicado: (2020)

Event-driven industrial robot control architecture for the Adept V+ platform
por: Semeniuta, Oleksandr, et al.
Publicado: (2019)

Green Route Synthesis and Characterization Techniques of Silver Nanoparticles and Their Biological Adeptness
por: Sharma, Nitin Kumar, et al.
Publicado: (2022)

Asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) longitudinal profiling study
por: Silkoff, P. E., et al.
Publicado: (2015)

Development of Inhibitor-Directed Enzyme Prodrug Therapy (IDEPT) for Prostate Cancer
por: Martin, Stacy E., et al.
Publicado: (2014)

Enzyme Prodrug Therapy Achieves Site-Specific, Personalized Physiological Responses to the Locally Produced Nitric Oxide
por: Winther, Anna K., et al.
Publicado: (2018)

Substrate Mediated Enzyme Prodrug Therapy
por: Fejerskov, Betina, et al.
Publicado: (2012)

Enzyme Models—From Catalysis to Prodrugs
por: Breijyeh, Zeinab, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qk6o5daaa504h27ig2kuc25i5d